The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements - PubMed (original) (raw)
Review
The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements
Ya-Lin Chiu et al. Annu Rev Immunol. 2008.
Abstract
All retroviruses, including HIV-1, display species-specific patterns of infection. The impaired growth of these retroviruses in foreign and sometimes even in their natural hosts often stems from the action of potent host-encoded "viral restriction factors" that form important protective components of the innate immune system. The discovery of APOBEC3G and related cytidine deaminases as one class of host restriction factors and of the action of HIV-1 Vif as a specific APOBEC3G antagonist have stimulated intense scientific interest. This Vif-APOBEC3G axis now forms a very attractive target for development of an entirely new class of anti-HIV drugs. In this review, we summarize current understanding of the mechanism of action of the APOBEC3 family of enzymes, their intriguing regulation within cells, the impact of these enzymes on viral evolution and disease progression, and their roles in controlling not only the replication of exogenous retroviruses but also the retrotransposition of endogenous retroelements.
Similar articles
- APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R, Spadari S, Maga G. Franca R, et al. Med Sci Monit. 2006 May;12(5):RA92-8. Med Sci Monit. 2006. PMID: 16641889 Review. - HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
Santa-Marta M, Aires da Silva F, Fonseca AM, Rato S, Goncalves J. Santa-Marta M, et al. Mol Immunol. 2007 Jan;44(4):583-90. doi: 10.1016/j.molimm.2006.02.005. Epub 2006 Mar 31. Mol Immunol. 2007. PMID: 16580072 - Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
Chiu YL, Greene WC. Chiu YL, et al. Trends Immunol. 2006 Jun;27(6):291-7. doi: 10.1016/j.it.2006.04.003. Epub 2006 May 4. Trends Immunol. 2006. PMID: 16678488 Review. - Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T. Shirakawa K, et al. Virology. 2006 Jan 20;344(2):263-6. doi: 10.1016/j.virol.2005.10.028. Epub 2005 Nov 21. Virology. 2006. PMID: 16303161 - Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
Wichroski MJ, Robb GB, Rana TM. Wichroski MJ, et al. PLoS Pathog. 2006 May;2(5):e41. doi: 10.1371/journal.ppat.0020041. Epub 2006 May 12. PLoS Pathog. 2006. PMID: 16699599 Free PMC article.
Cited by
- The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses.
Lovšin N, Gangupam B, Bergant Marušič M. Lovšin N, et al. Pathogens. 2024 Feb 20;13(3):187. doi: 10.3390/pathogens13030187. Pathogens. 2024. PMID: 38535531 Free PMC article. Review. - HERVs: Expression Control Mechanisms and Interactions in Diseases and Human Immunodeficiency Virus Infection.
Mantovani F, Kitsou K, Magiorkinis G. Mantovani F, et al. Genes (Basel). 2024 Jan 31;15(2):192. doi: 10.3390/genes15020192. Genes (Basel). 2024. PMID: 38397182 Free PMC article. Review. - Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology.
Cherkasova EA, Chen L, Childs RW. Cherkasova EA, et al. Front Cell Infect Microbiol. 2024 Feb 6;14:1358470. doi: 10.3389/fcimb.2024.1358470. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38379771 Free PMC article. Review. - Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections.
Münz C. Münz C. Cancers (Basel). 2023 Dec 7;15(24):5739. doi: 10.3390/cancers15245739. Cancers (Basel). 2023. PMID: 38136285 Free PMC article. Review. - The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis.
Zhang S, Guo Y, Hu Y, Gao X, Bai F, Ding Q, Hou K, Wang Z, Sun X, Zhao H, Qu Z, Xu Q. Zhang S, et al. Front Immunol. 2023 Sep 21;14:1242972. doi: 10.3389/fimmu.2023.1242972. eCollection 2023. Front Immunol. 2023. PMID: 37809064 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI0277635P30GY/AI/NIAID NIH HHS/United States
- P01 HD40543/HD/NICHD NIH HHS/United States
- R01 AI065329-01/AI/NIAID NIH HHS/United States
- RR18928-01/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases